Newly diagnosed with inflammatory arthritis (NISMA)–development of a complex self-management intervention

Autor: L. H. Lindgren, T. Thomsen, A. de Thurah, M. Aadahl, M. L. Hetland, S. D. Kristensen, B. A. Esbensen

Publikováno v: BMC Health Services Research, Vol 23, Iss 1, Pp 1-12 (2023)

Abstract Background Patients newly diagnosed with inflammatory arthritis (IA) request regular consultations and support from health professionals to manage physiological, emotional, and social challenges. Evidence suggests that providing a tailored m

Externí odkaz: https://doaj.org/article/0516377720b8419bb8bd6bbadf9ab686

Effect of supervised high-intensity interval training on haemostasis in patients with coronary artery disease: a randomised controlled trial

Autor: J Kristiansen, E L Grove, T Sjurdarson, J Rasmussen, M Mohr, S D Kristensen, A M Hvas

Publikováno v: European Heart Journal. 43

Background Regular exercise training is recommended for patients with stable coronary artery disease (CAD), because it improves quality of life and reduces cardiovascular mortality and hospital admissions. CAD patients benefit from anti-thrombotic th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1852e51cffc163636340bb5c530bb7ad
https://doi.org/10.1093/eurheartj/ehac544.1217

Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm:an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis

Autor: U. Zeymer, S. D. Kristensen, R. De Caterina, J. Ten Berg, A. Hoes, J. McMurray, Deirdre Lane, Francisco Marin, Lars Rasmussen, Patrick Pullicino, Joao Morais, Shunichi Homma, Gerasimos Filippatos, Stefan Anker, Felicita Andreotti, Piotr Ponikowski, Gregory Lip

Publikováno v: Lip, G Y H, Ponikowski, P, Andreotti, F, Anker, S D, Filippatos, G, Homma, S, Morais, J, Pullicino, P, Rasmussen, L H, Marin, F & Lane, D A 2012, ' Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm : an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis ', Thrombosis and Haemostasis, vol. 108, no. 6, pp. 1009-1022 . https://doi.org/10.1160/TH12-08-0578

SummaryChronic heart failure (HF) with either reduced or preserved left ventricular (LV) ejection fraction is common and remains an extremely serious disorder with a high mortality and morbidity. Many complications related to heart failure can be rel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cafe6f45334035bfbafa4919e94afb1
https://vbn.aau.dk/da/publications/14b338bf-aade-4507-9a68-e45a4ca0130f

Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial

Autor: Henning, Kelbaek, Leif, Thuesen, Steffen, Helqvist, Peter, Clemmensen, Lene, Kløvgaard, Anne, Kaltoft, Bente, Andersen, Helle, Thuesen, Thomas, Engstrøm, Hans E, Bøtker, Kari, Saunamäki, Lars R, Krusell, Erik, Jørgensen, Hans-Henrik T, Hansen, Evald H, Christiansen, Jan, Ravkilde, Lars, Køber, Klaus F, Kofoed, Christian J, Terkelsen, Jens F, Lassen, S D, Kristensen

Publikováno v: Kelbaek, H, Thuesen, L, Helqvist, S, Clemmensen, P, Kløvgaard, L, Kaltoft, A, Andersen, B, Thuesen, H H H, Engstrøm, T, Bøtker, H E, Saunamäki, K, Krusell, L R, Jørgensen, E, Hansen, H-H T, Christiansen, E H, Ravkilde, J, Køber, L, Kofoed, K F, Terkelsen, C J, Lassen, J F & DEDICATION Investigators 2008, ' Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial ', Circulation, vol. 118, no. 11, pp. 1155-62 . https://doi.org/10.1161/CIRCULATIONAHA.107.758698

Background— Implantation of drug-eluting stents (DES) limits the rate of coronary restenosis in most patients with coronary artery disease, but data are scarce with regard to their use in patients with ST-segment–elevation myocardial infarction a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ec9ebcc4ee315d740f395558dab52f
https://pubmed.ncbi.nlm.nih.gov/18725489

Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial

Autor: B K, Ziegler, S D, Kristensen, H, Vissinger, H K, Jensen, H K, Nielsen, S E, Husted

Publikováno v: Thrombosis research. 104(3)

Acetylsalicylic acid (ASA) is now a standard treatment of acute myocardial infarction (AMI). ASA inhibits thromboxane A(2) (TXA(2)) production by blocking the constitutive cyclooxygenase (COX)-1 enzyme, but only to a small degree the inducible COX-2.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::72ae9741f67f3de2ac6ebb3c0e2ddd1e
https://pubmed.ncbi.nlm.nih.gov/11672759